Photo of Inga-Marlene Pietsch

Inga-Marlene Pietsch

Inga-Marlene Pietsch is an intellectual property lawyer in Covington’s Life Sciences Transactions team assisting clients in protecting and enforcing their most valuable assets.  She works closely with other teams across the firm in particular the Corporate and Regulatory teams.

Inga has an extensive contentious and non-contentious IP practice advising companies from the Life Sciences and Technology sectors on complex IP issues with a particular focus on patents. Her previous experience in patent litigation gives Inga a unique perspective on IP issues that arise.

Inga’s clients include start-up companies as well as large corporations advising throughout the company life cycle.

Inga regularly advises clients on:

  • IP aspects in transactions
  • IP strategy and landscaping
  • Third party IP risk assessments
  • IP ownership and entitlement
  • IP validity assessments
  • Cross-border IP issues
  • Supplementary Protection Certificates

Inga also advises clients on managing and protecting their trade secrets and confidential information, assisting clients in auditing and identifying their trade secrets and putting procedures and processes in place to establish good trade secrets and confidential information handling practices.

Prior to her legal career Inga completed a Ph.D. in Organic Chemistry and worked for a custom synthesis start-up company.

Supplementary Protection Certificates (SPCs) are a form of patent term extension right that are available in the EU for medicinal products.

Tune into this episode of Covington’s Life Sciences Audiocast where Inga Pietsch and Roderick Dirkzwager discuss some of the developments in SPC case law from the European Court of

Continue Reading EU Talking Life Sciences Audiocast: Supplementary Protection Certificates – What It Means for a Product to Be Protected by a Basic Patent in Force and Future Proposals in the EU

Today, the World Intellectual Property Organization (“WIPO”) finished the preparatory session for the draft International Legal Instrument Relating to Intellectual Property, Genetic Resources and Traditional Knowledge Associated with Genetic Resources (the “Instrument”), which will be discussed and adopted at a diplomatic conference in 2024.

At the

Continue Reading WIPO proposes new Patent Disclosure obligations on Genetic Resources: What impact for companies?